Efficacy and safety of zolpidem extended release in elderly primary insomnia patients

American Journal of Geriatric Psychiatry

Volumn 16, Issue 1, 2008, Pages 44-57

  Walsh, James K ^a,b,e   Soubrane, Christina ^c   Roth, Thomas ^d  

^a ST LUKE S HOSPITAL   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c SANOFI   (France)

^d HENRY FORD HOSPITAL   (United States)

^e Sleep Medicine and Research Center   (United States)

Author keywords

Elderly; Extended release zolpidem; Hypnotic medication; Primary insomnia

Indexed keywords

HYPNOTIC AGENT; PLACEBO; ZOLPIDEM; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FALLING; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL CONCENTRATION; MULTICENTER STUDY; PATIENT SATISFACTION; POLYSOMNOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SELF REPORT; SIDE EFFECT; SLEEP TIME; SOMNOLENCE; TREATMENT RESPONSE; WAKEFULNESS; WITHDRAWAL SYNDROME; ANALYSIS OF VARIANCE; DELAYED RELEASE FORMULATION; DRUG EFFECT; DRUG TOXICITY; SLEEP;

AGED; ANALYSIS OF VARIANCE; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG TOXICITY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PATIENT SATISFACTION; POLYSOMNOGRAPHY; PYRIDINES; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 39749120856     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181256b01     Document Type: Article

References (19)

1. Swainston-Harrison T, Keating GM: Zolpidem: a review of its use in the management of insomnia. CNS Drugs 2005; 19:65-89
2. Besset A, Tafti M, Villemin E, Borderies P, Billard M: Effects of zolpidem on the architecture and cyclical structure of sleep in poor sleepers. Drugs Exp Clin Res 1995; 21:161-169
3. Drover DR: Comparative pharmacokinetics and pharmacodynam-ics of short-acting hypnosedatives: zaleplon, zolpidem and zopi-clone. Clin Pharmacokinetics 2004; 43:227-238
4. Staner L, Ertlé S, Boeijinga P, et al: Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychop-harmacology, 2005; 181:780-798
5. Weinling E, McDougall S, Andre F, Bianchetti G, Dubruc C: Pharmacokinetic profile of a new modified-release formulation of zolpidem designed to improve sleep maintenance. Fund Clin Pharmacology 2006; 20:397-403
6. Hindmarch I, Stanley N, Legangneux E, Emegbo S: Zolpidem modified-release 12.5 mg improves measures of sleep continuity in a model of sleep disturbance (traffic noise) compared with standard zolpidem 10 mg. Pharmacotherapy 2005; 25:1504
7. Roth T, Soubrane C, Titeux L, Walsh JK, on behalf of the Zoladult Study Group: Efficacy and safety of zolpidem-MR: A double-blind, placebo-controlled study in adults with primary insomnia. Sleep Med 2006; 7:397-406
8. Hindmarch I, Legangneux E, Stanley N, Emegbo S, Dawson J: A double-blind, placebo-controlled investigation of the residual psy-chomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers. Br J Clin Pharmacol 2006; 62:538-545
9. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Ed., Text Revision. Washington DC, American Psychiatric Association, 2000
10. Weschler D: Weschler Adult Intelligence Scale (Revised 1981). New York, The Psychological Corporation, 1981
11. Lezak MD: Neuropsychological assessment, 3rd ed. New York, Oxford University Press, 1995
12. Rechtschaffen A, Kales A: A manual for standardized terminology, techniques and scoring system for sleep stages of human patients. Bethesda, MD, National Institutes of Health,1968
13. Hohagen F, Kappler C, Schramm E, et al: Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening-Temporal stability of subtypes in a longitudinal study on general practice attendees. Sleep 1994; 17:551-554
14. Soldatos C, Dikeos D, Whitehead A: Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacology 1999; 14: 287-303
15. Darcourt G, Pringuey D, Salliere D, Lavoisy J: The safety and tolerability of zolpidem-an update. J Psychopharmacol 1999; 13:81-93
16. Walsh JK, Roth T, Randazzo A, et al: Eight weeks of nonnightly use of zolpidem for primary insomnia. Sleep 2000; 23:1087-1096
17. Perlis ML, McCall WV, Krystal AD, Walsh JK: Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 2004; 65:1128-1137
18. Asnis GM, Chakraburtty A, DuBoff EA: Zolpidem in SSRI-treated patients with persistent insomnia. J Clin Psychiatry 1999; 60:668- 676
19. Dorsey CM, Lee KA, Scharf MB: Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. Clin Ther 2004; 26:1578-1586